July 31, 2026 · Form 4 insider transaction
Uihlein Richard E bought 2,550,932 shares of Galectin Therapeutics Inc. at $4.05 per share, a transaction worth $10.33M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.